|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Net cash provided by operating activities | |||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Stock-based compensation | |||||
| Amortization of deferred sales commissions | |||||
| Depreciation and other amortization | |||||
| Amortization of intangible assets | |||||
| Putnam Investments | |||||
| Total amortization of intangible assets | |||||
| Impairment of intangible asset | |||||
| Net losses (gains) on investments | |||||
| Income from investments in equity method investees | |||||
| Net (gains) losses on investments of consolidated investment products | |||||
| Net purchase of investments by consolidated investment products | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in receivables and other assets | |||||
| Decrease in investments, net | |||||
| Increase (decrease) in accrued compensation and benefits | |||||
| Decrease in income taxes payable | |||||
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | |||||
| Increase (decrease) in accounts payable and accrued expenses of consolidated investment products | |||||
| Net cash provided by operating activities | |||||
| Net cash used in investing activities | |||||
| Purchase of investments | |||||
| Liquidation of investments | |||||
| Purchase of investments by consolidated collateralized loan obligations | |||||
| Payments of deferred consideration liability | |||||
| Liquidation of investments by consolidated collateralized loan obligations | |||||
| Decrease in loan receivables, net | |||||
| Additions of property and equipment, net | |||||
| Acquisitions, net of cash acquired (including $281.4 in cash and cash equivalents of consolidated investment products in fiscal year 2024) | |||||
| Payments of contingent consideration asset | |||||
| Net deconsolidation of investment products | |||||
| Net cash used in investing activities | |||||
| Net cash provided by financing activities | |||||
| Issuance of common stock | |||||
| Dividends paid on common stock | |||||
| Repurchase of common stock | |||||
| Proceeds from repurchase agreement | |||||
| Payments on repurchase agreement | |||||
| Proceeds from debt | |||||
| Payment of debt issuance costs | |||||
| Payments on debt | |||||
| Proceeds from loan | |||||
| Proceeds from debt of consolidated investment products | |||||
| Payments on debt by consolidated investment products | |||||
| Payments on contingent consideration liabilities | |||||
| Noncontrolling interests | |||||
| Net cash provided by financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Consolidated Investment Products | |||||
| Cash and Cash Equivalents, End of Year | |||||
| Consolidated Investment Products | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Cash paid for interest by consolidated investment products | |||||
| Noncash or Part Noncash Acquisition, Investments Acquired | |||||
Loading...